Table of Content

1. Executive Summary
   1.1. Anxiety Disorders and Depression Treatment Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2023 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Drug Type Adoption Analysis
   3.2. Regulatory Landscape
   3.3. Value Chain Analysis
       3.3.1. List of Distribution Channel/Marketplaces
           3.3.1.1. Retail
           3.3.1.2. Audiology
           3.3.1.3. E-Commerce
       3.3.2. List of End User (Industry)
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
4. Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
   4.3. Anxiety Disorders and Depression Treatment Market Outlook: Drug Class
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2018-2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
           4.3.3.1. Antidepressants
           4.3.3.2. Anxiolytics
           4.3.3.3. Anticonvulsants
           4.3.3.4. Noradrenergic Agents
           4.3.3.5. Atypical Antipsychotics
   4.4. Market Attractiveness Analysis: Drug Class
   4.5. Anxiety Disorders and Depression Treatment Market Outlook: Indication
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2018-2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
           4.5.3.1. Anxiety
           4.5.3.2. Depression
   4.6. Market Attractiveness Analysis: Indication
   4.7. Anxiety Disorders and Depression Treatment Market Outlook: Distribution Channel
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018-2022
       4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
           4.7.3.1. Hospital Pharmacy
           4.7.3.2. Retail Pharmacy
           4.7.3.3. Online Pharmacy
   4.8. Market Attractiveness Analysis: Distribution Channel
5. Anxiety Disorders and Depression Treatment Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018-2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023-2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   6.1. Key Highlights
   6.2. Pricing Analysis
   6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
       6.3.1. By Country
       6.3.2. By Drug Class
       6.3.3. By Indication
       6.3.4. By Distribution Channel
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
       6.4.1. U.S.
       6.4.2. Canada
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
       6.5.1. Antidepressants
       6.5.2. Anxiolytics
       6.5.3. Anticonvulsants
       6.5.4. Noradrenergic Agents
       6.5.5. Atypical Antipsychotics
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
       6.6.1. Anxiety
       6.6.2. Depression
   6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
       6.7.1. Hospital Pharmacy
       6.7.2. Retail Pharmacy
       6.7.3. Online Pharmacy
   6.8. Market Attractiveness Analysis
7. Europe Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   7.1. Key Highlights
   7.2. Pricing Analysis
   7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
       7.3.1. By Country
       7.3.2. By Drug Class
       7.3.3. By Indication
       7.3.4. By Distribution Channel
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
       7.4.1. Germany
       7.4.2. France
       7.4.3. U.K.
       7.4.4. Italy
       7.4.5. Spain
       7.4.6. Russia
       7.4.7. Türkiye
       7.4.8. Rest of Europe
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
       7.5.1. Antidepressants
       7.5.2. Anxiolytics
       7.5.3. Anticonvulsants
       7.5.4. Noradrenergic Agents
       7.5.5. Atypical Antipsychotics
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
       7.6.1. Anxiety
       7.6.2. Depression
   7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
       7.7.1. Hospital Pharmacy
       7.7.2. Retail Pharmacy
       7.7.3. Online Pharmacy
   7.8. Market Attractiveness Analysis
8. East Asia Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   8.1. Key Highlights
   8.2. Pricing Analysis
   8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
       8.3.1. By Country
       8.3.2. By Drug Class
       8.3.3. By Indication
       8.3.4. By Distribution Channel
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
       8.4.1. China
       8.4.2. Japan
       8.4.3. South Korea
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
       8.5.1. Antidepressants
       8.5.2. Anxiolytics
       8.5.3. Anticonvulsants
       8.5.4. Noradrenergic Agents
       8.5.5. Atypical Antipsychotics
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
       8.6.1. Anxiety
       8.6.2. Depression
   8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
       8.7.1. Hospital Pharmacy
       8.7.2. Retail Pharmacy
       8.7.3. Online Pharmacy
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   9.1. Key Highlights
   9.2. Pricing Analysis
   9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
       9.3.1. By Country
       9.3.2. By Drug Class
       9.3.3. By Indication
       9.3.4. By Distribution Channel
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
       9.4.1. India
       9.4.2. Southeast Asia
       9.4.3. ANZ
       9.4.4. Rest of South Asia & Oceania
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
       9.5.1. Antidepressants
       9.5.2. Anxiolytics
       9.5.3. Anticonvulsants
       9.5.4. Noradrenergic Agents
       9.5.5. Atypical Antipsychotics
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
       9.6.1. Anxiety
       9.6.2. Depression
   9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
       9.7.1. Hospital Pharmacy
       9.7.2. Retail Pharmacy
       9.7.3. Online Pharmacy
   9.8. Market Attractiveness Analysis
10. Latin America Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   10.1. Key Highlights
   10.2. Pricing Analysis
   10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
       10.3.1. By Country
       10.3.2. By Drug Class
       10.3.3. By Indication
       10.3.4. By Distribution Channel
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
       10.4.1. Brazil
       10.4.2. Mexico
       10.4.3. Rest of Latin America
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
       10.5.1. Antidepressants
       10.5.2. Anxiolytics
       10.5.3. Anticonvulsants
       10.5.4. Noradrenergic Agents
       10.5.5. Atypical Antipsychotics
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
       10.6.1. Anxiety
       10.6.2. Depression
   10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
       10.7.1. Hospital Pharmacy
       10.7.2. Retail Pharmacy
       10.7.3. Online Pharmacy
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
   11.1. Key Highlights
   11.2. Pricing Analysis
   11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
       11.3.1. By Country
       11.3.2. By Drug Class
       11.3.3. By Indication
       11.3.4. By Distribution Channel
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
       11.4.1. GCC Countries
       11.4.2. Egypt
       11.4.3. South Africa
       11.4.4. Northern Africa
       11.4.5. Rest of Middle East & Africa
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
       11.5.1. Antidepressants
       11.5.2. Anxiolytics
       11.5.3. Anticonvulsants
       11.5.4. Noradrenergic Agents
       11.5.5. Atypical Antipsychotics
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
       11.6.1. Anxiety
       11.6.2. Depression
   11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
       11.7.1. Hospital Pharmacy
       11.7.2. Retail Pharmacy
       11.7.3. Online Pharmacy
   11.8. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Pfizer Inc
           12.3.1.1. Overview
           12.3.1.2. Segments and Drug Class
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. H. Lundbeck A/S
       12.3.3. Glaxo SmithKline Pharmaceuticals Ltd.
       12.3.4. Merck & Co., Inc.
       12.3.5. Eli Lilly & Company
       12.3.6. AstraZeneca
       12.3.7. Bristol-Myers Squibb
       12.3.8. Johnson & Johnson
       12.3.9. AbbVie Inc.
       12.3.10. Sanofi
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations